Wall Street modifies stance on Dr. Reddy’s amid mixed earnings and rising institutional interest

Wall Street firms have adjusted their ratings on Dr. Reddy’s Laboratories following a mixed quarterly report, with some upgrading to ‘hold’ while overall sentiment remains cautious amid fluctuating investor interest. Wall Street Zen has raised Dr. Reddy’s Laboratories from “sell”…















